| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.11 | 0.4 |